Salmeterol Xinafoate (Systemic, Oral Inhalation) (Monograph) - Drugs.com
2024年9月10日 · Salmeterol is used only concomitantly with long-term asthma controller therapy (e.g., inhaled corticosteroids) for treatment of asthma and prevention of bronchospasm in patients with reversible obstructive airway disease, including symptoms of nocturnal asthma.
Fluticasone Propionate-Salmeterol Xinafoate Inhalation: Uses ... - WebMD
Find patient medical information for fluticasone propionate-salmeterol xinafoate inhalation on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user...
Salmeterol: Indications, Side Effects, Warnings - Drugs.com
2024年4月19日 · It is used to treat asthma. It is used to treat COPD (chronic obstructive pulmonary disease). It is used to prevent breathing problems that happen with exercise. This medicine is not to be used to treat intense flare-ups of shortness of breath. Use a rescue inhaler. Talk with the doctor. What do I need to tell my doctor BEFORE I take Salmeterol?
Salmeterol inhalation Uses, Side Effects & Warnings - Drugs.com
2024年9月23日 · What is salmeterol inhalation? Salmeterol inhalation is a bronchodilator that is used to prevent asthma attacks or exercise-induced bronchospasm. Salmeterol inhalation is also used to treat chronic obstructive pulmonary disease …
Salmeterol - Wikipedia
Salmeterol is a long-acting β 2 adrenergic receptor agonist (LABA) used in the maintenance and prevention of asthma symptoms and maintenance of chronic obstructive pulmonary disease (COPD) symptoms. [2]
Salmeterol (inhalation route) - Mayo Clinic
Inhaled salmeterol is used to prevent asthma attacks and to treat chronic obstructive pulmonary disease (COPD). It is not used to relieve an asthma attack that has already started.
Salmeterol - StatPearls - NCBI Bookshelf - National Center for ...
2023年5月23日 · Salmeterol has been shown to increase FEV1 and the FEV1/FVC ratio in both asthma and COPD patients. Following the approval in 1994 of salmeterol xinafoate, the FDA approved fluticasone propionate/salmeterol (FP/SAL) as a fixed-dose combination therapy for the treatment of asthma and COPD.
Salmeterol Xinafoate | C36H45NO7 | CID 56801 - PubChem
Salmeterol xinafoate is a naphthoic acid. ChEBI SALMETEROL XINAFOATE is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 4 approved and 2 investigational indications.
Serevent Diskus (Salmeterol Xinafoate): Side Effects, Uses ... - RxList
2021年8月25日 · Serevent Diskus (salmeterol xinafoate) is a bronchodilator used to prevent asthma attacks. Serevent Diskus will not treat an asthma attack that has already begun. Serevent Diskus is also used to treat chronic obstructive pulmonary disease including emphysema and chronic bronchitis. What Are Side Effects of Serevent Diskus?
Salmeterol xinafoate. A review of its pharmacological ... - PubMed
Salmeterol xinafoate, like salbutamol (albuterol), is a saligenin derivative, and a selective beta 2-adrenoceptor agonist. It produces bronchodilation for at least 12 hours following inhalation of a single 50 micrograms dose. Salmeterol is intended for …